|
 ABLE and Bio
Spectrum are pleased to bring you the results of THE EIGHTH SURVEY on Indian Biotech Industry.
Top 20 companies
Click here to read the Seventh surveyClick here to read the Sixth surveyClick here to read the Fifth surveyClick here to read the Fourth surveyClick here to read the Third surveyClick here to read the Second surveyClick here to read the First survey
 OPPORTUNITIES AND BARRIERS IN THE BIOSIMILAR MARKET:
Biopharmaceutical drugs (or biologics) have outperformed the pharmaceutical market as a whole largely due to two factors: they address areas of clinical need that are unmanageable with conventional therapeutics (including many cancers and genetic diseases) and they are able to command a premium price. More...
National Biotechnology Development Strategy
The National Biotechnology Development Strategy has been approved by the Government of India. The strategy is an outcome of a two-year-long nationwide consultation process. Click here
|
Lives
